Key Quantitative Figures

Standalone Financials (Q1 FY2027)

  • Revenue from operations: ₹639.89 lakh
  • Other income: ₹47.35 lakh
  • Total income: ₹687.24 lakh
  • Total expenses: ₹761.18 lakh
  • Loss before tax: ₹(73.94) lakh
  • Tax credit: ₹(23.74) lakh
  • Net loss for the quarter: ₹(50.20) lakh
  • Basic and diluted EPS: ₹(1.00)
  • Paid-up equity share capital: ₹504.06 lakh (face value ₹10 per share)

Consolidated Financials (Q1 FY2027)

  • Revenue from operations: ₹3,303.97 lakh
  • Other income: ₹72.53 lakh
  • Total income: ₹3,376.50 lakh
  • Total expenses: ₹3,164.67 lakh
  • Profit before share of profit/(loss) of associate and tax: ₹211.83 lakh
  • Share in loss of an associate: ₹(7.43) lakh
  • Profit before tax: ₹204.40 lakh
  • Tax expense: ₹19.75 lakh
  • Net profit for the quarter: ₹184.65 lakh
  • Profit attributable to equity holders of parent: ₹100.69 lakh
  • Basic and diluted EPS: ₹2.00
  • Paid-up equity share capital: ₹504.06 lakh

Comparative Figures (Standalone)

  • Q1 FY2026 Revenue: ₹877.49 lakh; Net Loss: ₹(214.30) lakh
  • FY2026 Revenue: ₹2,564.41 lakh; Net Loss: ₹(356.79) lakh

Comparative Figures (Consolidated)

  • Q1 FY2026 Revenue: ₹3,230.51 lakh; Net Loss: ₹(64.07) lakh
  • FY2026 Revenue: ₹14,906.35 lakh; Net Profit: ₹302.71 lakh

Dates of Action

  • Board meeting date: August 12, 2026 (4:35 PM IST to 5:30 PM IST)
  • Financial period ended: June 30, 2026
  • Writ petition filed: July 29, 2026
  • Next hearing date for writ petition: August 19, 2026
  • Step-down subsidiary closure date: July 02, 2026
  • Labour Commissioner order date: September 04, 2025
  • Notice of demand received: July 13, 2026 (dated June 16, 2026)

Parties or Entities Involved

  • GKB Ophthalmics Limited (Holding Company)
  • GKB Ophthalmics Products FZE (Wholly Owned Subsidiary)
  • Prime Ophthalmics Products PTY Limited (Step-down Subsidiary, now closed)
  • Prescription Optical Products LLC (Subsidiary)
  • GSV Ophthalmics Private Limited (Subsidiary till November 21, 2025)
  • Lensco - The Lens Company (Subsidiary)
  • GKB Vision FZC (Associate, 49% Holding)
  • Labour Commissioner, Goa
  • Mamlatdar of Bardez Taluka
  • Hon'ble High Court (presumably Bombay High Court at Goa)
  • MSKA & Associates LLP (Statutory Auditors)

Purpose or Stated Rationale

  • The board meeting was held to approve and take on record the unaudited standalone and consolidated financial results for Q1 FY2027.
  • The writ petition was filed to challenge recovery proceedings initiated by the Labour Commissioner demanding ₹8.82 crore.
  • The closure of Prime Ophthalmics Products PTY Limited was undertaken due to challenges in generating sufficient revenue and business opportunities to avoid further financial losses.

Financial or Operational Impact

  • The company has provided for an exceptional item related to employee benefits under the new Labour Codes: ₹149.40 lakh for Q4 FY2026 and ₹178.99 lakh for FY2026.
  • The investment in Prime Ophthalmics Products PTY Limited (AED 169,325.58, approximately ₹43.50 lakh) has been written off during the quarter.
  • The closure of the step-down subsidiary is not expected to materially affect the company's overall consolidated revenue, business, and profitability.
  • The Labour Commissioner demand of ₹8.82 crore represents a contingent liability pending the outcome of the writ petition.

Capital Structure Impact

No change in paid-up equity share capital reported for the current quarter (₹504.06 lakh).

Cash Flow Implications

  • The Labour Commissioner demand of ₹8.82 crore, if upheld, would result in a significant cash outflow.
  • The write-off of investment in Prime Ophthalmics Products PTY Limited represents a non-cash impairment charge.

Forward-Looking Guidance

No explicit forward-looking guidance or management commentary provided in the disclosure.